Payment assistance

Like many vaccines, the cost of Menveo® for preteens and teens is covered by most health insurance plans. But for many families who might not have insurance—or who might otherwise have trouble paying for the vaccine—there’s help available.

The following information is a summary of the requirements for VFC coverage and is provided for informational purposes only. To access the websites containing the actual coverage requirements, click here.

There’s a good chance the cost of your child’s Menveo vaccination is covered

It can be simple and inexpensive to have your child vaccinated against meningococcal disease:

  • All or most of the cost of vaccines is usually covered for families with health insurance
  • Free vaccine is available through the Vaccines for Children (VFC) program for children aged 18 and younger if they are: Medicaid eligible, uninsured, underinsured, or American Indian or Alaska Native1
  • Most pediatricians in the United States can provide the VFC service. Check with your doctor
  • If your child doesn’t have a regular doctor, contact your state health department, your local health department, or neighborhood health clinic about getting the Menveo vaccine2

Learn more about the VFC Program here or call 1-800-CDC-INFO (232-4636).

Indication

Menveo is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menveo is approved for use in persons 2 to 55 years of age. Menveo does not prevent N. meningitidis serogroup B infections.

Important Safety Information

You should not receive Menveo if you have had a severe allergic reaction to any ingredient of the vaccine, or if you have had a severe allergic reaction to a vaccine containing similar components as Menveo.

Side effects to Menveo include pain at the injection site, headache, muscle pain, fatigue, nausea, and fainting. Sometimes fainting is accompanied by falling with injury. Other side effects may occur.

Following vaccination with another US-licensed meningococcal conjugate vaccine, an evaluation of postmarketing adverse events suggested a potential for increased risk of Guillain-Barré Syndrome (GBS). There is not enough information to evaluate if a risk of GBS exists following administration of Menveo.

Tell your doctor if you are pregnant or planning to get pregnant.

Vaccination with Menveo may not protect all individuals.

For more information about Menveo, talk to your health-care professional.

Menveo.com has been developed by Novartis Vaccines as part of the company’s commitment to individual and public health.

References

  1. Vaccines & immunizations. How can I get help paying for vaccines? Centers for Disease Control and Prevention Web site. http://www.cdc.gov/vaccines/spec-grps/preteens-adol/help-pay.htm. Accessed March 3, 2010.
  2. Vaccines & immunizations. VFC Operations Guide. Module 1 – Overview. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/vaccines/programs/vfc/operations-guide.htm. Accessed June 4, 2010.
  3. Vaccines & immunizations. VFC: For parents. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/vaccines/programs/vfc/parents/default.htm. Accessed March 3, 2010.

Menveo.com Exit Notice

You are now leaving the Menveo.com site and moving to an external website independently operated and not managed by Novartis Vaccines and Diagnostics Inc. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or, click OK to continue.

OKCancel